HCPCS Level II C9603: Percutaneous Coronary Atherectomy, Additional Branch
Commercial payers pay $6212 on average nationally for this procedure.
HCPCS Level II code C9603 describes a percutaneous transluminal coronary atherectomy procedure performed with placement of a drug-eluting intracoronary stent and coronary angioplasty when performed, reported for each additional branch of a major coronary artery separate from the primary procedure; the service is a percutaneous coronary intervention typically performed in a hospital catheterization laboratory or interventional cardiology suite and is categorized as an interventional cardiovascular procedure.
For related coverage guidance, see recent payer policy updates: Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA), Cardiovascular Disease Risk Assessment, Biomarkers for Myocardial Infarction and Chronic Heart Failure.
Customize your policy alerts
Sign up for hcpcs C9603 policy alerts
Get alerted when payer policies referencing C9603 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for HCPCS C9603 centers on BUCA’s average commercial rate of $6,211.80, which serves as a midpoint reference among national payers. Blue Cross Blue Shield ($1,665.30 mean) and UnitedHealth Group ($4,195.20 mean) display lower central tendencies compared with Cigna ($18,436.00 mean) and Aetna ($5,097.40 mean), while BUCA’s mean sits above Aetna and UnitedHealth Group but well below Cigna’s very high mean. Minimums and maximums vary widely across payers but are not available for BUCA. Dispersion measured as the interquartile range (P75–P25) highlights substantial differences in consistency: Aetna’s IQR is $5,530.70, Blue Cross Blue Shield’s is $3,528.30, BUCA’s is $5,387.80, Cigna’s is $12,925.00, and UnitedHealth Group’s is $2,443.40. Cigna exhibits the widest IQR at $12,925.00, indicating the greatest spread between typical lower and upper quartile commercial rates, while UnitedHealth Group is the tightest at $2,443.40, indicating comparatively concentrated commercial pricing.